Snake venoms.
Snake venoms are complex mixtures containing many different biologically active proteins and peptides. A number of these proteins act on components of the haemostatic system in humans. The paper focuses on those venom constituents that affect the blood coagulation pathway, endothelial cells and platelets. Several highly purified venom enzymes have been used clinically as anticoagulants, and other venom proteins are being used in preclinical research to investigate their possible therapeutic potential. Haemostatically active components are distributed widely in the venom of many different snake species. In no case are all the components described below found in any single venom. Venom components can be grouped into several categories depending on their haemostatic effect. The following haemostatically active components are discussed in this chapter: enzymes that cause fibrinogen coagulation: enzymes that degrade fibrin(ogen); plasminogen activator; prothrombin activators; factor V activator; factor X activator; anticoagulant activities: enzymes with haemorrhagic activity; platelet aggregation inducers: and platelet aggregation inhibitors.
Markland
F S
FS
University of Southern California, School of Medicine, Los Angeles, USA.
D000818:Animals; D001777:Blood Coagulation / Q000187:drug effects*; D001779:Blood Coagulation Factors / Q000187:drug effects*; D006801:Humans; D012910:Snake Venoms / Q000201:enzymology* / Q000633:toxicity*; D012911:Snakes
D001779:Blood Coagulation Factors; D012910:Snake Venoms